Fate Therapeutics Q1 2026 Earnings EPS Beat Drives Stock Uptick Amid Continued Pipeline Progress FSI Q1 2026 Earnings EPS Misses Estimates Significantly Amid Operational Challenges OTIS Q1 2026 Earnings EPS Falls Short of Estimates Amid Mixed Demand IPWR Q1 2026 Earnings EPS Misses Estimates as Stock Declines 167 FSBW Q1 2026 Earnings Modest EPS Beat Highlights Stability Amid Soft Stock Response BTGO Q1 2026 Earnings Significant Earnings Miss Drives Stock Decline